Related Experiment Video
Updated: Jan 5, 2026

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Role of mTOR Signaling in Female Reproduction
Zaixin Guo1, Qi Yu1
1Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Abstract:
Mammalian target of rapamycin (mTOR) is a conserved serine/threonine kinase of the phosphatidylinositol kinase-related kinase family that regulates cell growth, metabolism, and autophagy. Extensive research has linked mTOR to several human diseases including cancer, neurodegenerative disorders, and aging. In this review, recent publications regarding the mechanisms underlying the role of mTOR in female reproduction under physiological and pathological conditions are summarized. Moreover, we assess whether strategies to improve or suppress mTOR expression could have therapeutic potential for reproductive diseases like premature ovarian failure, polycystic ovarian syndrome, and endometriosis.
Insights
The mammalian target of rapamycin (mTOR) pathway regulates female reproduction. This review explores mTOR
Area of Science:
- Reproductive biology and molecular medicine.
Background:
- The mammalian target of rapamycin (mTOR) is a key regulator of cell growth, metabolism, and autophagy.
- mTOR signaling is implicated in various human diseases, including cancer, neurodegeneration, and aging.
Purpose of the Study:
- To summarize recent findings on the role of mTOR in female reproduction under physiological and pathological conditions.
- To evaluate the therapeutic potential of modulating mTOR for reproductive disorders.
Main Methods:
- Review of current scientific literature on mTOR and female reproduction.
- Analysis of studies investigating mTOR's mechanisms in reproductive health and disease.
Main Results:
- mTOR plays a critical role in various aspects of female reproductive function.
- Dysregulation of mTOR is associated with conditions such as premature ovarian failure, polycystic ovary syndrome, and endometriosis.
Conclusions:
- Targeting the mTOR pathway presents a potential therapeutic strategy for managing female reproductive diseases.
- Further research is needed to fully elucidate mTOR's complex role and optimize therapeutic interventions.
More Related Videos
09:37A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
08:00Defining the Program of Maternal mRNA Translation during In vitro Maturation using a Single Oocyte Reporter Assay
Published on: June 16, 2021
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Yeast Signaling
Mitogens and the Cell Cycle
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...